From the Department of Paediatrics, Christchurch Public Hospital.
Department of Paediatric Infectious Diseases, Starship Children's Health, Auckland.
Pediatr Infect Dis J. 2022 Jan 1;41(1):66-71. doi: 10.1097/INF.0000000000003233.
Syphilis, a disease once in decline, has made a resurgence worldwide. New Zealand has had increasing syphilis rates since enhanced syphilis surveillance was initiated in 2013. This study reports epidemiologic, descriptive and treatment data on management of infants prenatally exposed or vertically infected with syphilis across New Zealand as reported by pediatricians.
Over a 26-month period from April 2018 to May 2020 (inclusive), pediatricians throughout New Zealand notified potential, probable and confirmed cases of congenital syphilis to the New Zealand Pediatric Surveillance Unit. National reporting numbers were concurrently ascertained to demonstrate reporting accuracy.
Thirty-two cases were notified, comprised of 25 infants born to women with positive antenatal syphilis serology (5 whom developed congenital syphilis), and 7 infants diagnosed with congenital syphilis after birth where syphilis was not diagnosed in pregnancy. There were 12 cases of congenital syphilis; an incidence rate of 9.4 cases per 100,000 live births. Nine of the 12 infants had clinical features of congenital syphilis. One-third of maternal infections were early syphilis, and the women who gave birth to infected infants were less likely to have received antenatal care, adequate treatment and follow-up monitoring of treatment for syphilis during pregnancy.
This study quantifies an important burden of disease from congenital syphilis in our population. Case finding and treatment of syphilis in pregnancy are critical to prevent this. Our findings support the urgent need for measures such as repeat maternal syphilis screening in early third trimester; whether by affected region or instituted for all, in the context of rising cases.
梅毒曾一度呈下降趋势,但现已在全球范围内卷土重来。自 2013 年加强梅毒监测以来,新西兰的梅毒发病率不断上升。本研究报告了新西兰儿科医生报告的先天梅毒感染胎儿的流行性病学、描述性和治疗数据。
在 2018 年 4 月至 2020 年 5 月(包括)的 26 个月期间,新西兰各地的儿科医生向新西兰儿科监测单位报告了先天梅毒的潜在、可能和确诊病例。同时确定了全国报告数字,以证明报告的准确性。
共报告了 32 例病例,其中 25 例婴儿的母亲产前梅毒血清学检查阳性(其中 5 例确诊为先天梅毒),7 例婴儿出生后诊断为先天梅毒,妊娠时未诊断出梅毒。有 12 例先天梅毒;发病率为每 100,000 例活产 9.4 例。12 例婴儿中有 9 例具有先天梅毒的临床特征。三分之一的母体感染为早期梅毒,且生育感染婴儿的母亲更不可能接受产前护理、充分的梅毒治疗以及妊娠期间治疗的随访监测。
本研究量化了先天梅毒在人群中造成的严重疾病负担。因此,妊娠期间发现和治疗梅毒至关重要。我们的研究结果支持采取措施的迫切需要,如在第三孕期早期重复进行母体梅毒筛查;无论在哪个地区实施,或在病例不断增加的情况下对所有地区实施。